Results 251 to 260 of about 52,371 (280)

Targeting epigenetics and ferroptosis in DLBCL

Blood, 2023
Nan Zhou, Luca Busino
openaire   +2 more sources

Top bar navigation

Frontiers in Immunology, 2023
Ken H Young, Ou Bai
exaly  

CircPCBP2 promotes the stemness and chemoresistance of DLBCL via targeting miR-33a/b to disinhibit PD-L1

Cancer Science, 2022
Yesheng Wang, Lingdi Zhao, Jianwei Du
exaly  

DLBCL

Oncology Times, 2013
openaire   +1 more source

MiR-665 suppresses the progression of diffuse large B cell lymphoma (DLBCL) through targeting LIM and SH3 protein 1 (LASP1)

Leukemia Research, 2022
Dongmei Guo, Qingliang Teng
exaly  

Engaging results with glofitamab in DLBCL

Nature Reviews Clinical Oncology, 2023
openaire   +2 more sources

Hematology

Hematology, 2023
Mingxia Zhu, Shaoxiang Li, Gehong Dong
exaly  

TCFL5 knockdown sensitizes DLBCL to doxorubicin treatment via regulation of GPX4

Cellular Signalling, 2023
Xie Yandong, Xueying Lu
exaly  

Improving Outcomes for Patients with Diffuse Large B-cell Lymphoma†

Ca-A Cancer Journal for Clinicians, 2010
Christopher R Flowers, Julie M Vose, Rajni Sinha   +2 more
exaly  

Simultaneous Inhibition of PI3Kδ and PI3Kα Induces ABC-DLBCL Regression by Blocking BCR-Dependent and -Independent Activation of NF-κB and AKT

Cancer Cell, 2017
Soon-Thye Lim, Dominik Mumberg, Soo Yong Tan   +2 more
exaly